SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016625
Filing Date
2022-11-07
Accepted
2022-11-07 16:18:17
Documents
85
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20220930x10q.htm   iXBRL 10-Q 2686683
2 EX-31.1 cara-20220930xex31d1.htm EX-31.1 12112
3 EX-31.2 cara-20220930xex31d2.htm EX-31.2 11948
4 EX-32.1 cara-20220930xex32d1.htm EX-32.1 10370
  Complete submission text file 0001558370-22-016625.txt   10934194

Data Files

Seq Description Document Type Size
5 EX-101.SCH cara-20220930.xsd EX-101.SCH 65007
6 EX-101.CAL cara-20220930_cal.xml EX-101.CAL 56253
7 EX-101.DEF cara-20220930_def.xml EX-101.DEF 331772
8 EX-101.LAB cara-20220930_lab.xml EX-101.LAB 524218
9 EX-101.PRE cara-20220930_pre.xml EX-101.PRE 473705
79 EXTRACTED XBRL INSTANCE DOCUMENT cara-20220930x10q_htm.xml XML 2197112
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 221365699
SIC: 2834 Pharmaceutical Preparations